PortfoliosLab logoPortfoliosLab logo
IAG vs. GMED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IAG vs. GMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IAMGOLD Corporation (IAG) and Globus Medical, Inc. (GMED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IAG achieves a -13.95% return, which is significantly lower than GMED's -9.76% return. Over the past 10 years, IAG has underperformed GMED with an annualized return of 10.35%, while GMED has yielded a comparatively higher 12.86% annualized return.


IAG

1D
-2.54%
1M
-10.02%
6M
-21.95%
YTD
-13.95%
1Y
109.91%
3Y*
76.06%
5Y*
38.95%
10Y*
10.35%
ALL TIME*
5.33%

GMED

1D
-1.83%
1M
3.73%
6M
-13.11%
YTD
-9.76%
1Y
49.71%
3Y*
10.13%
5Y*
-1.08%
10Y*
12.86%
ALL TIME*
13.68%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$96.46M$126.87M$149.45M
$76.33M$73.71M$89.43M

IAG vs. GMED - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IAG
IAMGOLD Corporation
-13.95%219.57%103.95%-1.94%-17.57%-14.71%-1.61%1.36%-36.88%51.43%
GMED
Globus Medical, Inc.
-9.76%5.56%55.21%-28.25%2.87%10.70%10.77%36.04%5.30%65.66%

Correlation

The correlation between IAG and GMED is 0.16, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.16

Correlation (3Y)
Balances recent behavior with more history.

0.15

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.18

Correlation (10Y)
Provides a long-term view across more market conditions.

0.11

Correlation (All Time)
Calculated using the full available price history since Aug 3, 2012

0.09

Fundamentals

Market Cap

IAG:

$8.20B

GMED:

$10.63B

EPS

IAG:

$1.73

GMED:

$4.28

PE Ratio

IAG:

8.22

GMED:

18.39

PEG Ratio

IAG:

0.05

GMED:

0.19

PS Ratio

IAG:

2.43

GMED:

3.48

PB Ratio

IAG:

1.94

GMED:

2.30

Total Revenue (TTM)

IAG:

$3.42B

GMED:

$3.10B

Gross Profit (TTM)

IAG:

$1.64B

GMED:

$1.58B

EBITDA (TTM)

IAG:

$1.97B

GMED:

$803.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IAG vs. GMED — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

IAG
IAG Risk / Return Rank: 8484
Overall Rank
IAG Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
IAG Sortino Ratio Rank: 8383
Sortino Ratio Rank
IAG Omega Ratio Rank: 8383
Omega Ratio Rank
IAG Calmar Ratio Rank: 8484
Calmar Ratio Rank
IAG Martin Ratio Rank: 8080
Martin Ratio Rank

GMED
GMED Risk / Return Rank: 8080
Overall Rank
GMED Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
GMED Sortino Ratio Rank: 8383
Sortino Ratio Rank
GMED Omega Ratio Rank: 8080
Omega Ratio Rank
GMED Calmar Ratio Rank: 8282
Calmar Ratio Rank
GMED Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

IAG vs. GMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IAMGOLD Corporation (IAG) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IAGGMEDDifference
Sharpe ratioReturn per unit of total volatility

+0.74

Sortino ratioReturn per unit of downside risk

0.00

Omega ratioGain probability vs. loss probability

1.29

1.26

+0.03

Calmar ratioReturn relative to maximum drawdown

2.55

2.26

+0.29

Martin ratioReturn relative to average drawdown

5.35

4.92

+0.43

IAG vs. GMED - Sharpe Ratio Comparison

The current IAG Sharpe Ratio is 1.75, which is higher than the GMED Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of IAG and GMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IAG vs. GMED - Drawdown Comparison

The maximum IAG drawdown since its inception was -95.55%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for IAG and GMED.


Loading charts...

Drawdown Indicators


IAGGMEDDifference

Max Drawdown

Largest peak-to-trough decline

-95.55%

-47.91%

-47.64%

Max Drawdown (1Y)

Largest decline over 1 year

-43.30%

-22.10%

-21.20%

Max Drawdown (3Y)

Largest decline over 3 years

-43.30%

-44.40%

+1.10%

Max Drawdown (5Y)

Largest decline over 5 years

-73.69%

-47.91%

-25.78%

Max Drawdown (10Y)

Largest decline over 10 years

-86.46%

-47.91%

-38.55%

Current Drawdown

Current decline from peak

-42.25%

-18.62%

-23.63%

Average Drawdown

Average peak-to-trough decline

-56.07%

-15.35%

-40.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.61%

10.13%

+10.48%

Volatility

IAG vs. GMED - Volatility Comparison

IAMGOLD Corporation (IAG) has a higher volatility of 15.14% compared to Globus Medical, Inc. (GMED) at 12.47%. This indicates that IAG's price experiences larger fluctuations and is considered to be riskier than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IAGGMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.14%

12.47%

+2.67%

Volatility (6M)

Calculated over the trailing 6-month period

48.40%

26.28%

+22.12%

Volatility (1Y)

Calculated over the trailing 1-year period

62.98%

49.44%

+13.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

60.60%

38.45%

+22.15%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

58.53%

35.41%

+23.12%

Dividends

IAG vs. GMED - Dividend Comparison

Neither IAG nor GMED has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

IAG vs. GMED - Financials Comparison

This section allows you to compare key financial metrics between IAMGOLD Corporation and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

IAG vs. GMED - Profitability Comparison

The chart below illustrates the profitability comparison between IAMGOLD Corporation and Globus Medical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

IAG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, IAMGOLD Corporation reported a gross profit of 570.70M and revenue of 1.03B. Therefore, the gross margin over that period was 55.4%.

GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.

IAG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, IAMGOLD Corporation reported an operating income of 544.70M and revenue of 1.03B, resulting in an operating margin of 52.9%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.

IAG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, IAMGOLD Corporation reported a net income of 379.70M and revenue of 1.03B, resulting in a net margin of 36.9%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.


Frequently Asked Questions


IAG and GMED have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IAG has higher volatility (15.14%) compared to GMED (12.47%). In terms of maximum drawdown, IAG dropped -95.55% vs GMED's -47.91%.

IAG currently has the higher Sharpe Ratio (1.75 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IAG and GMED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer